Page last updated: 2024-08-25

nedaplatin and Peritoneal Carcinomatosis

nedaplatin has been researched along with Peritoneal Carcinomatosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chikazawa, K; Imai, K; Ishiguro, A; Kimura, A; Konno, R; Kuwata, T; Netsu, S; Wang, L1
Fujiwara, K; Goto, T; Hasegawa, K; Iwasa, N; Nagao, S; Ohishi, R; Shimizu, M; Takano, M1
Ota, T; Takeshima, N; Takizawa, K1

Other Studies

3 other study(ies) available for nedaplatin and Peritoneal Carcinomatosis

ArticleYear
Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin.
    Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Case-Control Studies; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies

2020
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome

2010
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly?
    European journal of gynaecological oncology, 2011, Volume: 32, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids

2011